Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Abstract Introduction Dimethyl fumarate (DMF) showed favorable benefit-risk in patients with relapsing-remitting multiple sclerosis (MS) in phase 3 DEFINE and CONFIRM trials and in the ENDORSE extension study. Disease activity can differ in younger patients with MS compared with the overall populati...

Full description

Bibliographic Details
Main Authors: Lilyana Amezcua, Yang Mao-Draayer, Wendy S. Vargas, Rebecca Farber, Sara Schaefer, Filipe Branco, Sarah M. England, Nicholas Belviso, James B. Lewin, Jason P. Mendoza, Sai L. Shankar, the ENDORSE Study Investigators
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-04-01
Series:Neurology and Therapy
Subjects:
Dimethyl fumarate
DMT
Efficacy
Multiple sclerosis
Safety
Young adults
Online Access:https://doi.org/10.1007/s40120-023-00475-8

Internet

https://doi.org/10.1007/s40120-023-00475-8

Similar Items